Still on this train. The CR wasn't for operational expenses. It was for product development to change the revenue trajectory from Baseline to Growth on that chart shown in my earlier post. Based on the company's numbers out in the public forum, they're going to generate an extra $1.5billion in sales over the next 5 years. More than doubling the already impressive CAGR from 35% pa to 78% pa. And all before any sales from TAVR are taken into account. All for a few million bucks in a CR. Are you really as upset about all this as you make out to be? Do you truly wish the CR had not occurred and these benefits we will all share in were forfeited?
- Forums
- ASX - By Stock
- $200m+ Sales in 2 years
Still on this train. The CR wasn't for operational expenses. It...
- There are more pages in this discussion • 101 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$21.50 |
Change
0.210(0.99%) |
Mkt cap ! $413.0M |
Open | High | Low | Value | Volume |
$21.50 | $21.50 | $21.00 | $247.6K | 11.68K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $21.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$21.50 | 244 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 21.200 |
1 | 412 | 21.150 |
1 | 493 | 21.100 |
1 | 949 | 21.000 |
1 | 500 | 20.800 |
Price($) | Vol. | No. |
---|---|---|
21.500 | 244 | 1 |
21.600 | 300 | 1 |
21.700 | 421 | 1 |
22.200 | 107 | 1 |
22.610 | 254 | 1 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
$21.21 |
  |
Change
0.210 ( 0.09 %) |
|||
Open | High | Low | Volume | ||
$21.19 | $21.21 | $21.19 | 143 | ||
Last updated 14.24pm 06/05/2024 ? |
Featured News
AVR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online